Transparent Cap-assisted SpyGlass for Biliary Stricture

Sponsor
Affiliated Hospital to Academy of Military Medical Sciences (Other)
Overall Status
Recruiting
CT.gov ID
NCT05320497
Collaborator
(none)
10
1
1
3.5
2.8

Study Details

Study Description

Brief Summary

The transparent cap-assisted endoscope has the function of fixing field of view and increasing visual space. It has been widely used in gastrointestinal examination and treatment. In this study, the investigators intend to apply transparent cap-assisted choledochoscopy to endoscopic biliary tract exploration and biopsy to investigate whether transparent cap-assisted choledochoscopy can improve operability, visual field clarity, and biopsy accuracy.

Condition or Disease Intervention/Treatment Phase
  • Device: Transparent cap
N/A

Detailed Description

Recently, endoscopy has become more widely used in clinical practice. A straightforward method of improving mucosal visualization involves attachment of a transparent cap to the end of the endoscope. It has been widely used in gastrointestinal examination and treatment.This is a before-after study. In patients with suspected bile duct stricture, tandem ERCP combined with SpyGlass choledochoscopy procedures were carried out on the same day in random order, first without a transparent cap and then with a cap (without-to-with), or first with a cap and then without a cap (with-to-without). The differences in maneuverability, visual field clarity and biopsy accuracy of choledochoscopy with and without transparent cap were recorded to explore the application prospect of transparent cap assisted choledochoscopy.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
This is a before-after study. Transparent cap SpyGlass and standard SpyGlass were performed on the same patient successively.This is a before-after study. Transparent cap SpyGlass and standard SpyGlass were performed on the same patient successively.
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Application of Transparent Cap-assisted Digital Cholangioscopy (SpyGlassTM) for Biliary Stricture
Actual Study Start Date :
Apr 14, 2022
Anticipated Primary Completion Date :
Jul 10, 2022
Anticipated Study Completion Date :
Jul 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Transparent cap-assisted SpyGlass

Add a transparent cap to the end of the SpyGlass choledochoscopy

Device: Transparent cap
Add a self-made transparent cap (made by cutting a silicone drainage tube) to the end of the SpyGlass choledochoscope, and then perform routine choledochoscopy and biopsy operations

Outcome Measures

Primary Outcome Measures

  1. The clearness of visual field [Immediately]

    The clearness of visual field was evaluated by the operating physician and was rated as "clear" or "not clear."

  2. Intubation rates of bile duct ends, cystic duct openings, and left and right hepatic duct bifurcations [Immediately]

    Comparison of intubation rates between transparent cap SpyGlass and standard SpyGlass

Secondary Outcome Measures

  1. Biopsy accuracy [1 week]

    Biopsy accuracy between clear cap SpyGlass and standard SpyGlass was evaluated by comparing the coincidence rate of biopsy histopathology and postoperative pathology

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • The indications for ERCP.

  • Written informed consent

Exclusion Criteria:
  • Underlying bleeding disorder

  • The platelet count less than 50×10^9/L

  • Serious cardio-pulmonary, hepatic or renal disease

  • Intolerance to ERCP

  • Other high-risk conditions or disease (such as massive ascites, etc.)

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Fifth Medical Center of Chinese PLA General Hosptial Beijing Beijing China 100039

Sponsors and Collaborators

  • Affiliated Hospital to Academy of Military Medical Sciences

Investigators

  • Principal Investigator: Yan Liu, MD, Beijing 302 Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Affiliated Hospital to Academy of Military Medical Sciences
ClinicalTrials.gov Identifier:
NCT05320497
Other Study ID Numbers:
  • Transparent Cap
First Posted:
Apr 11, 2022
Last Update Posted:
Apr 15, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Affiliated Hospital to Academy of Military Medical Sciences
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 15, 2022